Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.

Steinhausen HC, Bisgaard C.

Eur Neuropsychopharmacol. 2014 Feb;24(2):232-41. doi: 10.1016/j.euroneuro.2013.11.003. Epub 2013 Nov 18.

PMID:
24314850
[PubMed - indexed for MEDLINE]
2.

Abuse of methylphenidate in Germany: data from spontaneous reports of adverse drug reactions.

Gahr M, Freudenmann RW, Hiemke C, Kölle MA, Schönfeldt-Lecuona C.

Psychiatry Res. 2014 Jan 30;215(1):252-4. doi: 10.1016/j.psychres.2013.11.008. Epub 2013 Nov 18.

PMID:
24289907
[PubMed - indexed for MEDLINE]
3.

ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.

Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH.

Addict Behav. 2014 Jan;39(1):325-8. doi: 10.1016/j.addbeh.2013.09.002. Epub 2013 Sep 10.

PMID:
24090624
[PubMed - indexed for MEDLINE]
4.

Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.

Sembower MA, Ertischek MD, Buchholtz C, Dasgupta N, Schnoll SH.

J Addict Dis. 2013;32(1):26-38. doi: 10.1080/10550887.2012.759880.

PMID:
23480245
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; European ADHD Guidelines Group.

J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. doi: 10.1111/jcpp.12036. Epub 2013 Jan 7. Review.

PMID:
23294014
[PubMed - indexed for MEDLINE]
6.

[The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].

Frölich J, Banaschewski T, Spanagel R, Döpfner M, Lehmkuhl G.

Z Kinder Jugendpsychiatr Psychother. 2012 Sep;40(5):287-99; quiz 299-300. doi: 10.1024/1422-4917/a000185. German.

PMID:
22869222
[PubMed - indexed for MEDLINE]
7.

Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.

Klassen LJ, Bilkey TS, Katzman MA, Chokka P.

Curr Drug Abuse Rev. 2012 Sep;5(3):190-8. Review.

PMID:
22571450
[PubMed - indexed for MEDLINE]
8.

Oppositional defiant disorder in adults with ADHD.

Reimherr FW, Marchant BK, Olsen JL, Wender PH, Robison RJ.

J Atten Disord. 2013 Feb;17(2):102-13. doi: 10.1177/1087054711425774. Epub 2011 Nov 18.

PMID:
22100691
[PubMed - indexed for MEDLINE]
9.

Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder.

Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC.

J Child Adolesc Psychopharmacol. 2011 Oct;21(5):455-63. doi: 10.1089/cap.2011.0014.

PMID:
22040190
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[Alcoholic foetopathy: an update].

Martín Fernández-Mayoralas D, Fernández-Jaén A.

Rev Neurol. 2011 Mar 1;52 Suppl 1:S53-7. Review. Spanish.

PMID:
21365604
[PubMed - indexed for MEDLINE]
Free Article
11.

Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.

Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D.

J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903-14. doi: 10.1016/j.jaac.2011.06.010. Epub 2011 Aug 4.

PMID:
21871372
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008.

Frauger E, Pauly V, Natali F, Pradel V, Reggio P, Coudert H, Thirion X, Micallef J.

CNS Drugs. 2011 May;25(5):415-24. doi: 10.2165/11587640-000000000-00000.

PMID:
21476612
[PubMed - indexed for MEDLINE]
13.

A case of suicide attempt with long-acting methylphenidate (Concerta).

Ozdemir E, Karaman MG, Yurteri N, Erdogan A.

Atten Defic Hyperact Disord. 2010 Nov;2(3):103-5. doi: 10.1007/s12402-010-0026-y. Epub 2010 May 25.

PMID:
21432595
[PubMed - indexed for MEDLINE]
14.

[Infantile psychosis secondary to methylphenidate].

Fernández-Fernández MA, Rufo-Campos M, Mateos-Checa R, Muñoz-Cabello B, Madruga-Garrido M, Blanco-Martínez B.

Rev Neurol. 2011 Apr 1;52(7):446-7. Spanish. No abstract available.

PMID:
21425116
[PubMed - indexed for MEDLINE]
Free Article
15.

The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.

van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.

Clin Psychol Psychother. 2012 May-Jun;19(3):270-8. doi: 10.1002/cpp.750. Epub 2011 Mar 14.

PMID:
21404369
[PubMed - indexed for MEDLINE]
16.

Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.

Rowles BM, Findling RL.

Dev Disabil Res Rev. 2010;16(3):273-82. doi: 10.1002/ddrr.120. Review.

PMID:
20981766
[PubMed - indexed for MEDLINE]
17.

Oral megadose methylphenidate ingestion for suicide attempt.

Poulton A.

Pediatr Int. 2010 Oct;52(5):852. doi: 10.1111/j.1442-200X.2010.03222.x. No abstract available.

PMID:
20880313
[PubMed - indexed for MEDLINE]
18.

Oral megadose methylphenidate ingestion for suicide attempt.

Fettahoglu EC, Satilmis A, Gokcen C, Ozatalay E.

Pediatr Int. 2009 Dec;51(6):844-5. doi: 10.1111/j.1442-200X.2009.02929.x. No abstract available.

PMID:
20158630
[PubMed - indexed for MEDLINE]
19.

Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.

McLaren JL, Cauble S, Barnett RJ.

J Clin Psychopharmacol. 2010 Feb;30(1):77-8. doi: 10.1097/JCP.0b013e3181c92eb2. No abstract available.

PMID:
20075654
[PubMed - indexed for MEDLINE]
20.

Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.

Janols LO, Liliemark J, Klintberg K, von Knorring AL.

Nord J Psychiatry. 2009 Nov;63(6):508-16. doi: 10.3109/08039480903154534.

PMID:
19958258
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk